The host-vector system developed jointly by Professor Yasuhiko Suzuki (Division of Research Support)and Fuso Pharmaceutical Industries, Ltd. has been commercialized by the company as Contract cell construction services.

This commissioned project will be carried out using a recombinant protein mass expression vector that utilizes mammalian cells as a host, which was jointly developed by Professor Suzuki and Fuso Pharmaceutical Industries, Ltd.

【References】: Canada Patent 2748011, EU patent 2385115, Korea Patent 10-1655492, Hong Kong Patent HK1161898, US Patent 9,096,878, Japan Patent 5704753, Australia Patent 2009331326, China Patent 102325881